Toxicity Grade

Known as: TOXGR 
A ranking of the poisonous nature of an object.
National Institutes of Health

Topic mentions per year

Topic mentions per year

1983-2018
0102019832018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
PURPOSE To test for a possible correlation between high-grade acute organ toxicity during primary radiochemotherapy and treatment… (More)
Is this relevant?
2010
2010
To evaluate toxicity after dose-escalated radiotherapy for prostate cancer using intensity-modulated treatment planning (IMRT… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 3
Is this relevant?
2010
2010
To test for a possible correlation between high-grade acute organ toxicity during primary radio(chemo)therapy and treatment… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2009
Highly Cited
2009
BACKGROUND Isolated limb infusion (ILI) is a minimally invasive approach for treating in-transit extremity melanoma, with only… (More)
  • figure 2
Is this relevant?
Highly Cited
2009
Highly Cited
2009
A frequent manifestation of advanced NSCLC is malnutrition, even though there are many studies which relate it with a poor… (More)
  • table 1
  • table 3
  • table 2
Is this relevant?
2009
2009
PURPOSE In selected patients with muscle-invasive bladder cancer, combined-modality therapy (transurethral resection bladder… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
PURPOSE To compare acute and late gastrointestinal (GI) and genitourinary (GU) side effects in prostate cancer patients… (More)
Is this relevant?
2005
2005
BACKGROUND Recent explorations suggest that women may experience more severe 5-fluorouracil (5-FU)-related toxicity than men. The… (More)
Is this relevant?
1999
1999
This retrospective study had the following aims: (a) calculation of actuarial rate of late radiation toxicity after whole-brain… (More)
Is this relevant?
1993
1993
BACKGROUND The toxicity of a given cancer therapy is an important end point in clinical trials examining the potential costs and… (More)
Is this relevant?